{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:55:44Z","timestamp":1777589744893,"version":"3.51.4"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.expneurol.2011.06.004","type":"journal-article","created":{"date-parts":[[2011,6,25]],"date-time":"2011-06-25T23:15:40Z","timestamp":1309043740000},"page":"160-170","source":"Crossref","is-referenced-by-count":13,"title":["An angiogenic inhibitor, cyclic RGDfV, attenuates MPTP-induced dopamine neuron toxicity"],"prefix":"10.1016","volume":"231","author":[{"given":"Aditiben","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe V.","family":"Toia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalea","family":"Colletta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brinda Desai","family":"Bradaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Carvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bill","family":"Hendey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.06.004_bb0005","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0165-5728(91)90067-H","article-title":"Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue","volume":"32","author":"Akiyama","year":"1991","journal-title":"J. Neuroimmunol."},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2011.06.004_bb0010","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1007\/s100720200065","article-title":"Striatal dopaminergic denervation in early and late onset Parkinson's disease assessed by PET and the tracer [11C]FECIT: preliminary findings in one patient with autosomal recessive parkinsonism (Park2)","volume":"23","author":"Antonini","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.nbd.2009.05.018","article-title":"The blood\u2013brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates\u2014evidence from in vivo neuroimaging studies","volume":"35","author":"Astradsson","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0014-5793(91)81101-D","article-title":"Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1","volume":"291","author":"Aumailley","year":"1991","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0025","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0002-9440(10)63369-X","article-title":"Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways","volume":"165","author":"Baluk","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0030","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-004-0256-2","article-title":"Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian","volume":"112","author":"Barcia","year":"2005","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0035","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2741\/1145","article-title":"Blood vessels and parkinsonism","volume":"9","author":"Barcia","year":"2004","journal-title":"Front. Biosci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0040","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.neuint.2009.03.014","article-title":"Altered expression of tight junction proteins and matrix metalloproteinases in thiamine-deficient mouse brain","volume":"55","author":"Beauchesne","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0045","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2010.08.011","article-title":"Blood\u2013brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE","volume":"229","author":"Bennett","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00229549","article-title":"6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor.","volume":"111","author":"Bowenkamp","year":"1996","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0055","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin Invest."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0060","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/S0959-8049(96)00381-4","article-title":"Role of integrins in angiogenesis","volume":"32A","author":"Brooks","year":"1996","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.7512751","article-title":"Requirement of vascular integrin alpha v beta 3 for angiogenesis","volume":"264","author":"Brooks","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0070","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/0092-8674(94)90007-8","article-title":"Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels","volume":"79","author":"Brooks","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0075","first-page":"233","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a multifunctional angiogenic cytokine","volume":"79","author":"Brown","year":"1997","journal-title":"EXS"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0080","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2009.06319.x","article-title":"The blood\u2013brain barrier in neurodegenerative disease: a rhetorical perspective","volume":"111","author":"Carvey","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0085","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1460-9568.2005.04281.x","article-title":"6-Hydroxydopamine-induced alterations in blood\u2013brain barrier permeability","volume":"22","author":"Carvey","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0090","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.expneurol.2009.09.027","article-title":"Glutamate, excitotoxicity, and programmed cell death in Parkinson disease","volume":"220","author":"Caudle","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s00125-001-0727-z","article-title":"Kinetics of integrin expression in the mouse model of proliferative retinopathy and success of secondary intervention with cyclic RGD peptides","volume":"45","author":"Chavakis","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0100","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","article-title":"Caffeine protects against MPTP-induced blood\u2013brain barrier dysfunction in mouse striatum","volume":"107","author":"Chen","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0105","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.4049\/jimmunol.1000208","article-title":"Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease","volume":"185","author":"Chung","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0110","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5483\/BMBRep.2010.43.4.225","article-title":"The role of neuroinflammation on the pathogenesis of Parkinson's disease","volume":"43","author":"Chung","year":"2010","journal-title":"BMB Rep"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/1535-7163.MCT-07-0552","article-title":"Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization","volume":"7","author":"Claes","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.expneurol.2011.06.004_bb0120","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1002\/mds.22718","article-title":"Protein degradation, aggregation, and misfolding","volume":"25","author":"Cuervo","year":"2010","journal-title":"Mov. Disord."},{"issue":"Pt 8","key":"10.1016\/j.expneurol.2011.06.004_bb0125","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00702-009-0226-9","article-title":"Evidence of angiogenic vessels in Alzheimer's disease","volume":"116","author":"Desai","year":"2009","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0135","first-page":"234","article-title":"The microtubule cytoskeleton in human phagocytic leukocytes is a highly dynamic structure","volume":"66","author":"Ding","year":"1995","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0140","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1091\/mbc.E02-04-0241","article-title":"Microtubule asymmetry during neutrophil polarization and migration","volume":"13","author":"Eddy","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0145","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s11064-008-9747-0","article-title":"Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration","volume":"33","author":"Fato","year":"2008","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0150","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(99)00641-8","article-title":"Blood vessels change in the mesencephalon of patients with Parkinson's disease","volume":"353","author":"Faucheux","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0155","doi-asserted-by":"crossref","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","article-title":"Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain","volume":"137","author":"Fernstrom","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0160","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1126\/science.270.5241.1500","article-title":"Definition of two angiogenic pathways by distinct alpha V integrins","volume":"270","author":"Friedlander","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ceb.2005.08.010","article-title":"Integrin regulation","volume":"17","author":"Ginsberg","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afp223","article-title":"Ageing, neurodegeneration and Parkinson's disease","volume":"39","author":"Hindle","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neulet.2009.12.059","article-title":"Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter","volume":"470","author":"Holley","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0180","first-page":"741","article-title":"Vitronectin receptor: tissue specific expression or adaptation to culture?","volume":"71","author":"Horton","year":"1990","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0185","doi-asserted-by":"crossref","first-page":"F89","DOI":"10.1083\/jcb.150.2.F89","article-title":"The evolution of cell adhesion","volume":"150","author":"Hynes","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0190","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/01.STR.32.5.1208","article-title":"Enhanced expression of Iba1, ionized calcium-binding adapter molecule 1, after transient focal cerebral ischemia in rat brain","volume":"32","author":"Ito","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0195","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0200","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1006\/bbrc.2001.5809","article-title":"A novel synthetic Arg-Gly-Asp-containing peptide cyclo(\u2212RGDf==V-) is the potent inhibitor of angiogenesis","volume":"288","author":"Kawaguchi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1042\/BJ20081055","article-title":"Regulation of gene expression by hypoxia","volume":"414","author":"Kenneth","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0215","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jns.2003.10.016","article-title":"Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?","volume":"217","author":"Kirk","year":"2004","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0220","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006995910836","article-title":"Tight junctions of the blood\u2013brain barrier","volume":"20","author":"Kniesel","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0225","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11481-009-9176-0","article-title":"Neuroinflammation in Parkinson's disease","volume":"4","author":"Lee","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0235","doi-asserted-by":"crossref","first-page":"228","DOI":"10.2337\/db09-0902","article-title":"Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0240","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1600-0773.1985.tb00020.x","article-title":"Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues","volume":"57","author":"Lyden","year":"1985","journal-title":"Acta Pharmacol. Toxicol. (Copenh)"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0245","first-page":"163","article-title":"Angiogenesis\u2014a self-adapting principle in hypoxia","author":"Marti","year":"2005","journal-title":"EXS"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0250","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood-2006-05-023580","article-title":"Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells","volume":"108","author":"Maubant","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0255","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/glia.20799","article-title":"Microglial expression of alphavbeta3 and alphavbeta5 integrins is regulated by cytokines and the extracellular matrix: beta5 integrin null microglia show no defects in adhesion or MMP-9 expression on vitronectin","volume":"57","author":"Milner","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0260","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.4049\/jimmunol.170.7.3850","article-title":"The extracellular matrix and cytokines regulate microglial integrin expression and activation","volume":"170","author":"Milner","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0265","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1098-1136(199712)21:4<350::AID-GLIA2>3.0.CO;2-7","article-title":"Expression of alpha vbeta3 and alpha vbeta8 integrins during oligodendrocyte precursor differentiation in the presence and absence of axons","volume":"21","author":"Milner","year":"1997","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10456-008-9099-z","article-title":"Vascular permeability, vascular hyperpermeability and angiogenesis","volume":"11","author":"Nagy","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0275","first-page":"469","article-title":"Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity","volume":"16","author":"Nwanze","year":"1995","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/BF01291884","article-title":"Alterations in the distribution of glutathione in the substantia nigra in Parkinson's disease","volume":"104","author":"Pearce","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0285","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0169-328X(94)90254-2","article-title":"Distribution of the tight junction-associated protein ZO-1 in circumventricular organs of the CNS","volume":"21","author":"Petrov","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0290","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1523\/JNEUROSCI.19-05-01541.1999","article-title":"Integrin subunit gene expression is regionally differentiated in adult brain","volume":"19","author":"Pinkstaff","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0295","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/01.wnr.0000130539.39937.1d","article-title":"Angiogenic signaling in Alzheimer's disease","volume":"15","author":"Pogue","year":"2004","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0300","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0305","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2009.01.009","article-title":"VEGF and angiogenesis in acute and chronic MOG((35\u201355)) peptide induced EAE","volume":"209","author":"Roscoe","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0310","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/0092-8674(86)90259-X","article-title":"Arg-Gly-Asp: a versatile cell recognition signal","volume":"44","author":"Ruoslahti","year":"1986","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0315","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10456-006-9030-4","article-title":"In vivo characterization of endothelial cell activation in a transgenic mouse model of Alzheimer's disease","volume":"9","author":"Schultheiss","year":"2006","journal-title":"Angiogenesis"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0320","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.2741\/3066","article-title":"TNF: a master switch for inflammation to cancer","volume":"13","author":"Sethi","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0325","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/jnr.21073","article-title":"Inhibition of integrin alphavbeta3 reduces blood-brain barrier breakdown in focal ischemia in rats","volume":"84","author":"Shimamura","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0330","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10456-009-9141-9","article-title":"Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis","volume":"12","author":"Somanath","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0335","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0306-4522(97)00570-8","article-title":"The neurotoxin 1-methyl-4-phenylpyridinium is sequestered within neurons that contain the vesicular monoamine transporter","volume":"84","author":"Speciale","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0340","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/08916930903143083","article-title":"Angiogenesis in rheumatoid arthritis","volume":"42","author":"Szekanecz","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JAD-2006-10114","article-title":"Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease","volume":"10","author":"Thirumangalakudi","year":"2006","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0350","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors","volume":"64","author":"Tong","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0355","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mds.1037","article-title":"Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice","volume":"16","author":"Turmel","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0360","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(03)12521-4","article-title":"Alzheimer's disease and angiogenesis","volume":"361","author":"Vagnucci","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0365","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-0-387-72005-0_28","article-title":"Role of IL-1-mediated inflammation in tumor angiogenesis","volume":"601","author":"Voronov","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0370","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.wnr.0000215769.71657.65","article-title":"Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease","volume":"17","author":"Wada","year":"2006","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0375","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0380","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1537-1891(02)00200-8","article-title":"Tight junctions of the blood\u2013brain barrier: development, composition and regulation","volume":"38","author":"Wolburg","year":"2002","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0385","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2007.05.012","article-title":"Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease","volume":"206","author":"Yasuda","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0390","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00001756-200502080-00011","article-title":"Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus","volume":"16","author":"Zand","year":"2005","journal-title":"NeuroReport"},{"key":"10.1016\/j.expneurol.2011.06.004_bb0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2008.08.030","article-title":"Sensitive and selective liquid chromatography\/tandem mass spectrometry methods for quantitative analysis of 1-methyl-4-phenyl pyridinium (MPP+) in mouse striatal tissue","volume":"874","author":"Zhang","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.expneurol.2011.06.004_bb0400","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","article-title":"TNF-alpha knockout and minocycline treatment attenuates blood\u2013brain barrier leakage in MPTP-treated mice","volume":"26","author":"Zhao","year":"2007","journal-title":"Neurobiol. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.expneurol.2011.06.004_bb0405","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.3233\/JAD-2010-100363","article-title":"Mitochondrial dysfunction in Parkinson's disease","volume":"20","author":"Zhu","year":"2010","journal-title":"J. Alzheimers Dis."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611002263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T03:43:07Z","timestamp":1712547787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611002263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0014488611002263"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.06.004","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}